Exercise Training Attenuates MuRF-1 Expression in the Skeletal Muscle of Patients With Chronic Heart Failure Independent of Age

Background—Muscle wasting occurs in both chronic heart failure (CHF) and normal aging and contributes to exercise intolerance and increased morbidity/mortality. However, the molecular mechanisms of muscle atrophy in CHF and their interaction with aging are still largely unknown. We therefore measured the activation of the ubiquitin-proteasome system and the lysosomal pathway of intracellular proteolysis in muscle biopsies of CHF patients and healthy controls in two age strata and assessed the age-dependent effects of a 4-week endurance training program on the catabolic-anabolic balance. Methods and Results—Sixty CHF patients (30 patients aged ≤55 years, mean age 46±5 years; 30 patients aged ≥65 years, mean age 72±5 years) and 60 healthy controls (30 subjects aged ≤55 years, mean age 50±5 years; 30 subjects aged ≥65 years, mean age 72±4 years) were randomized to 4 weeks of supervised endurance training or to a control group. Before and after the intervention, vastus lateralis muscle biopsies were obtained....

[1]  G. Schuler,et al.  Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure , 2012, European journal of preventive cardiology.

[2]  A. Russell,et al.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy , 2011, Pflügers Archiv - European Journal of Physiology.

[3]  A. Goldberg,et al.  Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway* , 2010, The Journal of Biological Chemistry.

[4]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[5]  S. Welle,et al.  Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure , 2010, Circulation.

[6]  W. Kraus,et al.  Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study. , 2009, American heart journal.

[7]  K. Esser,et al.  FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner. , 2009, American journal of physiology. Cell physiology.

[8]  W. Blum,et al.  Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay. , 2009, Experimental and clinical endocrinology.

[9]  P. Greenhaff,et al.  The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. , 2008, Biochimica et biophysica acta.

[10]  S. M. Senf,et al.  Hsp70 overexpression inhibits NF‐κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  N. Offner,et al.  The initiation factor eIF3‐f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy , 2008, The EMBO journal.

[12]  B. Schoser,et al.  Molecular biomarkers monitoring human skeletal muscle fibres and microvasculature following long‐term bed rest with and without countermeasures , 2008, Journal of anatomy.

[13]  E. Volpi,et al.  Amino acid metabolism and regulatory effects in aging , 2008, Current opinion in clinical nutrition and metabolic care.

[14]  S. Rakhilin,et al.  The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. , 2007, Cell metabolism.

[15]  L. Lerman,et al.  Ubiquitin and ubiquitin-like proteins in protein regulation. , 2007, Circulation research.

[16]  Nicholas Ling,et al.  Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism , 2006 .

[17]  I. Janssen.  Influence of Sarcopenia on the Development of Physical Disability: The Cardiovascular Health Study , 2006, Journal of the American Geriatrics Society.

[18]  D. Taillandier,et al.  Lysosomal proteolysis in skeletal muscle. , 2005, The international journal of biochemistry & cell biology.

[19]  I. Richard,et al.  Calpains in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[20]  G. Schuler,et al.  Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[21]  D. Mann,et al.  TNF-acts via p 38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1 / MAFbx in skeletal muscle , 2005 .

[22]  V. Sirri,et al.  Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase* , 2005, Journal of Biological Chemistry.

[23]  Naftali Kaminski,et al.  Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. , 2004, Journal of applied physiology.

[24]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[25]  R. Ross,et al.  Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. , 2004, American journal of epidemiology.

[26]  G. Schuler,et al.  Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[27]  Heather Smith,et al.  Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. , 2003, American journal of physiology. Endocrinology and metabolism.

[28]  S. Lecker.  Ubiquitin‐protein ligases in muscle wasting: multiple parallel pathways? , 2003, Current opinion in clinical nutrition and metabolic care.

[29]  C. Gregorio,et al.  Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.

[30]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[31]  A. Goldberg,et al.  The N-end Rule Pathway Catalyzes a Major Fraction of the Protein Degradation in Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[32]  P. Poole‐Wilson,et al.  Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. , 1998, Journal of the American College of Cardiology.

[33]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[34]  B. Saltin,et al.  High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement. , 1996, European heart journal.

[35]  W L Beaver,et al.  Anaerobic threshold and respiratory gas exchange during exercise. , 1973, Journal of applied physiology.

[36]  U. Wisløff,et al.  Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility. , 2007, Cardiovascular research.

[37]  W. Mitch,et al.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. , 2004, The Journal of clinical investigation.

[38]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.